loadpatents
name:-0.011950016021729
name:-0.012161016464233
name:-0.0015370845794678
Inoue; Takayo Patent Filings

Inoue; Takayo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Inoue; Takayo.The latest application filed is for "methods of identifying hsp90 inhibitors with less ocular toxicity".

Company Profile
2.14.12
  • Inoue; Takayo - Malden MA
  • - Malden MA US
  • Inoue; Takayo - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds for the treatment of proliferative disorders
Grant 9,090,603 - Sun , et al. July 28, 2
2015-07-28
Methods Of Identifying Hsp90 Inhibitors With Less Ocular Toxicity
App 20140127740 - Zhou; Dan ;   et al.
2014-05-08
Compounds For The Treatment Of Proliferative Disorders
App 20140045795 - Sun; Lijun ;   et al.
2014-02-13
Methods of identifying HSP90 inhibitors with less ocular toxicity
Grant 8,628,752 - Zhou , et al. January 14, 2
2014-01-14
Oral formulations of bis(thiohydrazide amides)
Grant 8,618,170 - Tatsuta , et al. December 31, 2
2013-12-31
Oral formulations of bis(thiohydrazide amides)
Grant 08618170 -
2013-12-31
Compounds for the treatment of proliferative disorders
Grant 8,598,366 - Sun , et al. December 3, 2
2013-12-03
Bis(thio-hydrazide amide) salts for treatment of cancers
Grant 8,461,208 - Koya , et al. June 11, 2
2013-06-11
Methods Of Identifying Hsp90 Inhibitors With Less Ocular Toxicity
App 20130109045 - Zhou; Dan ;   et al.
2013-05-02
Compounds For The Treatment Of Proliferative Disorders
App 20120289483 - Sun; Lijun ;   et al.
2012-11-15
Compounds for the treatment of proliferative disorders
Grant 8,269,017 - Sun , et al. September 18, 2
2012-09-18
Bis(thio-hydrazide Amide) Salts For Treatment Of Cancers
App 20120035266 - KOYA; Keizo ;   et al.
2012-02-09
Bis(thio-hydrazide amide) salts for treatment of cancers
Grant 8,048,925 - Koya , et al. November 1, 2
2011-11-01
Compounds For The Treatment Of Proliferative Disorders
App 20110059893 - Sun; Lijun ;   et al.
2011-03-10
Compounds for the treatment of proliferative disorders
Grant 7,884,094 - Sun , et al. February 8, 2
2011-02-08
Bis(thio-hydrazide Amide) Salts For Treatment Of Cancers
App 20100324143 - Koya; Keizo ;   et al.
2010-12-23
Oral Formulations Of Bis(thiohydrazide Amides)
App 20100311840 - Tatsuta; Noriaki ;   et al.
2010-12-09
Bis(thio-hydrazide amide) salts for treatment of cancers
Grant 7,795,313 - Koya , et al. September 14, 2
2010-09-14
Bis(thio-hydrazide Amide) Salts For Treatment Of Cancers
App 20090281172 - Koya; Keizo ;   et al.
2009-11-12
BIS (thio-hydrazide amide) salts for treatment of cancers
Grant 7,579,503 - Koya , et al. August 25, 2
2009-08-25
BIS (thio-hydrazide amide) salts for treatment of cancers
App 20080269340 - Koya; Keizo ;   et al.
2008-10-30
Bis(thio-hydrazide amide) salts for treatment of cancers
Grant 7,385,084 - Koya , et al. June 10, 2
2008-06-10
Compounds for the treatment of proliferative disorders
App 20060217389 - Sun; Lijun ;   et al.
2006-09-28
Bis(thio-hydrazide amide) salts for treatment of cancers
App 20060135595 - Koya; Keizo ;   et al.
2006-06-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed